Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for prevention of depression after moderate traumatic brain injury
IRCT20221108056446N9Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of citalopram in major depressive disorder (MDD), sponsored by Isfahan University of Medical Sciences. Started Sep 2024; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20221108056446N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221108056446N9.